2-Chlorooxazolo[4,5-b]pyridine monohydrochloride, 95.0%, 250mg

4,4',4'',4'''-(Ethane-1,1,2,2-tetrayl)tetraphenol, 95.0%, 1g

5-Methyl-1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 97%, 25g

4,4'-Thiodiphenol, 98.0%, 25g

1-(3-Nitrophenyl)-piperazine, 90.0%, 1g

2,4-Dimethoxy-6-methylbenzoic acid, 98%, 1g

2,4,6-trimethylpyridine hexafluorophosphate, 98%, 5g

Matraces aforados con tapón de vidrio, clase A Forma trapezoidal, 10 ml, 7/16, 2 Pieza(s)

5,6-difluoro-2H-1,2,3-benzotriazole, 97%, 100mg

2-Bromo-5-methylanisole, 98.0%, 10g

1-Cyclohexyl-piperazine, 98.0%, 25g

1-Propylpiperazine, 95.0%, 250mg

5-Bromo-2-(piperazin-1-yl)thiazole, 95+%, 1g